Skip to content

Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement

Noninvasive, Subharmonic Intra-Cardiac Pressure Measurement

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03243942
Enrollment
56
Registered
2017-08-09
Start date
2017-06-01
Completion date
2019-06-26
Last updated
2019-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Pressure, Cardiac Catheterization, Echocardiography, Heart Failure, Heart Ventricles

Keywords

pressure measurements, blood pressure, contrast echocardiography, ventricular pressures, catheterization

Brief summary

The fundamental hypothesis of this project is that real-time intracardiac pressures can be monitored and quantified noninvasively in humans using a novel contrast-enhanced ultrasound technique called subharmonic-aided pressure estimation (SHAPE).This study will use contrast echocardiography to assess the accuracy of SHAPE compared to simultaneously acquired intracardiac pressures measured invasively during cardiac catheterization. This study is designed to verify that contrast echocardiography using the SHAPE method, already proven in a canine model and tested in a human pilot study can be used as a surrogate for cardiac catheterization with sufficient accuracy to allow clinical applicability in humans.

Interventions

DRUGDefinity

Whenever a patient undergoes cardiac catheterization, which routinely includes intracardiac pressure monitoring using a pressure catheter, as part of their standard clinical care and agrees to participate in the study, we will acquire research data. With Definity infusion, SHAPE algorithm will be initiated to determine optimum acoustic pressure. Then, at the optimum acoustic pressure SHAPE specific data will be acquired from the cardiac chambers and aorta synchronously with the pressures recorded by the catheter (as a part of the patient's standard of care). After acquiring the ultrasound imaging data, the remainder of the heart catheterization will be completed by the attending cardiologist according to the patients' standard of care.

Sponsors

American Heart Association
CollaboratorOTHER
Lantheus Medical Imaging
CollaboratorINDUSTRY
Thomas Jefferson University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be scheduled for a cardiac catheterization procedure * Adult patients over the age of 21 * Acceptable baseline echocardiographic images in the supine position * If a female of child-bearing potential, must have a negative pregnancy test * Provide written informed consent

Exclusion criteria

* Clinically unstable patients, e.g., those who are clinically in decompensated heart failure or having active chest pain or presenting for admission with an unstable anginal syndrome * Patients in whom introduction of a catheter into the left ventricle is contraindicated or would potentially be dangerous, e.g., patients with active ventricular arrhythmias or with significant aortic valve stenosis where crossing the aortic valve may be difficult and not clinically necessary * Patients with anatomic right-to-left, bi-directional, or transient right-to-left cardiac shunts where Definity could traverse as a bolus * Patients with known hypersensitivity to Definity * Females who are pregnant or nursing

Design outcomes

Primary

MeasureTime frameDescription
Agreement between SHAPE and pressure catheter measurementsup to 1 dayCorrelation
Error between SHAPE and pressure catheter measurementsup to 1 dayANOVA/Post-hoc comparisons

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026